PET/CT imaging study for people with cancer
Part of Cancer, Hormones & metabolism clinical trials.
This study uses a special PET/CT scan to look at amino acid transporters in tumors. It may help doctors better understand and diagnose certain cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have suspected or known cancer (based on tests like MRI, CT, or biopsy).
- You have been scheduled for an AATS PET/CT scan as part of your care.
- You or your legal representative can sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special scan (Tau PET/CT) to look at tau protein in the brain or body. It may help doctors understand tau-related diseases better, and is open to adults who are scheduled for this scan.
This study is looking at how well a special type of PET/CT scan (called PSMA PET/CT) can see cancer in people who have or may have certain tumors. It may help doctors better understand and track the disease.
This trial tests how well a special PET/MRI scan can help doctors evaluate gliomas and brain metastases. It may help improve diagnosis and treatment planning by comparing scan results with tissue samples or surgery findings.
This early study uses a special PET/CT scan to see how much a specific cancer-related protein (PARP-1) is present in pheochromocytoma and paraganglioma. It may help doctors understand the biology of these tumors and how useful this scan could be in the future.
This trial uses a special PET scan to see how well it can find and track different types of cancer. It may help doctors better understand your cancer.
This trial studies a special PET scan called 18F-DOPA PET/CT to see if it can help doctors better manage brain tumors. It may be used before surgery, for radiation planning, or when MRI results are unclear.
Hear when a new Primary Hyperparathyroidism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.